Nicola Amodio PhD

Dr. Nicola Amodio, Ph.D. is an Assistant Professor of Pathology in the Department of Experimental and Clinical Medicine at the Magna Graecia University of Catanzaro. He completed her Doctor of Philosophy at the Magna Graecia University of Catanzaro. Dr. Nicola Amodio’s research has been the identification of novel molecularly-based therapies for cancers using integrated genomic/epigenomic analyses. Overall, NA research activity has provided novel insights into the molecular mechanisms of hematological malignancies, such as multiple myeloma, and the framework for the development of innovative anti-cancer therapeutics, using non-coding RNA- targeting oligonucleotides and small molecules. Nicola Amodio’s studies have led to the identification of novel cancer vulnerabilities, including non-coding RNAs and transcription factors, with diagnostic and therapeutic potential; his studies have been highly cited and discussed by journal editorials, and have provided the molecular rationale for ongoing clinical trials in Italian and US institutions using small molecules and microRNA antagonists to treat hematological malignancies.